Literature DB >> 1599505

A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine.

J S McElvain1, J O Schenk.   

Abstract

A study of Na+ and Cl- as co-substrates in dopamine uptake into striatal suspensions and inhibition of dopamine uptake by cocaine was made by monitoring the initial velocity of the uptake of exogenously added non-radioactively labeled dopamine using a rotating disk electroanalytical technique with 50 msec resolution. Dopamine, in the concentration range of 0.025 to 4.00 microM, was found to be taken up rapidly into the tissue phase of striatal suspensions following the apparent zero order rate law for the first 25 sec. The observed, dopamine concentration-dependent, initial velocity data were first analyzed graphically using the Eadie-Hofstee transformation of the Michaelis-Menten kinetic equation and, subsequently, using all of the velocity data and the results of the graphical analyses, by non-linear curve fitting. Dopamine uptake was found to be first order in dopamine with a Vmax of 582 pmol/sec/g wet weight and a Km of 1.2 microM. The results of experiments in which choline and isethionate were substituted for Na+ and Cl-, respectively, suggested that the uptake process is second order in Na+ and first order in Cl-. Multisubstrate analyses of the initial velocities of uptake over the concentration range of 0.025 to 1.5 microM dopamine suggested that the mechanism of binding of dopamine to the uptake carrier is a partially random, sequential mechanism where dopamine or Na+ binds first with the uptake carrier and Cl- binds last. Cocaine was found to uncompetitively inhibit dopamine uptake and competitively inhibit both Na+ and Cl- binding (apparent Km values: 131 and 51 mM, respectively), suggesting that the mechanism of cocaine inhibition may be to bind to the dopamine occupied uptake carrier complex at the Na+ binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599505     DOI: 10.1016/0006-2952(92)90178-l

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  31 in total

1.  Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

Authors:  Q Wu; M E Reith; M J Kuhar; F I Carroll; P A Garris
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.

Authors:  S L Ingram; S G Amara
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.

Authors:  M E Reith; C Xu; L Zhang; L L Coffey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

Authors:  H K Wayment; J O Schenk; B A Sorg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

5.  Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain.

Authors:  Kymry T Jones; Catherine Woods; Juan Zhen; Tamara Antonio; Kenneth D Carr; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-01-31       Impact factor: 5.372

Review 6.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

7.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

8.  Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.

Authors:  Bonnie A Merchant; Jeffry D Madura
Journal:  J Mol Graph Model       Date:  2012-06-19       Impact factor: 2.518

9.  Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.

Authors:  Kaustuv Saha; Danielle Sambo; Ben D Richardson; Landon M Lin; Brittany Butler; Laura Villarroel; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.